EP 1771477 A2 20070411 - IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GAL2GLCNAC2MAN3GLCNAC2 GLYCOFORM
Title (en)
IMMUNOGLOBULINS COMPRISING PREDOMINANTLY A GAL2GLCNAC2MAN3GLCNAC2 GLYCOFORM
Title (de)
IMMUNOGLOBULINE ENTHALTEND HAUPTSÄCHLICH DIE GAL2GLCNAC2MAN3GLCNAC2 GLYCOFORM
Title (fr)
IMMUNOGLOBULINES CONTENANT PRINCIPALEMENT UNE GLYCOFORME GAL2GLCNAC2MAN3GLCNAC2
Publication
Application
Priority
- US 2005025656 W 20050719
- US 59005204 P 20040721
- US 59003004 P 20040721
Abstract (en)
[origin: WO2006014683A2] The present invention relates to immunoglobulin glycoprotein compositions having predominant N-glycan structures on an immunoglobulin glycoprotein which confer a specific effector function. Additionally, the present invention relates to pharmaceutical compositions comprising an antibody having a particular enriched N-glycan structure, wherein said N-glycan structure is Gal<SUB>2</SUB>GlcNAc<SUB>2</SUB>Man<SUB>3</SUB>GlcNAc<SUB>2</SUB> lacking fucose.
IPC 8 full level
C07K 16/22 (2006.01)
CPC (source: EP)
A61P 7/04 (2017.12); A61P 7/06 (2017.12); A61P 17/00 (2017.12); A61P 19/02 (2017.12); A61P 29/00 (2017.12); A61P 31/00 (2017.12); A61P 35/00 (2017.12); A61P 37/02 (2017.12); C07K 16/00 (2013.01); C07K 16/2896 (2013.01); C07K 2317/24 (2013.01); C07K 2317/41 (2013.01)
Citation (search report)
See references of WO 2006014683A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006014683 A2 20060209; WO 2006014683 A3 20060608; AU 2005269763 A1 20060209; CA 2573842 A1 20060209; EP 1771477 A2 20070411; JP 2008515772 A 20080515
DOCDB simple family (application)
US 2005025656 W 20050719; AU 2005269763 A 20050719; CA 2573842 A 20050719; EP 05790299 A 20050719; JP 2007522676 A 20050719